| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/06/2008 | CN100366253C 1,2,4-benzotriazine oxides formulations |
| 02/06/2008 | CN100366251C Organic compounds |
| 02/06/2008 | CN100366250C Freeze dried vinpocetine powder injection and its preparation process |
| 02/06/2008 | CN100366249C Control releasing administration system for temozolomide |
| 02/06/2008 | CN100366248C Skin care composition for mediating cell to cell communication |
| 02/06/2008 | CN100366247C Single nitrate isosorbide delayed-release tablets |
| 02/06/2008 | CN100366244C Local used composition containing antifungal agent |
| 02/06/2008 | CN100366243C Process for preparation of dispersions |
| 02/06/2008 | CN100366240C Ultraviolet-shielding type patch |
| 02/06/2008 | CN100366239C Soft capsules |
| 02/06/2008 | CN100366238C Freeze dried polyene lecithin powder for injection and its prepn |
| 02/05/2008 | USRE40045 Combined preparation of salmeterol or a salt (1-hydroxy-2-naphthalenecarboxylate salt) and fluticasone propionate for simultaneous, sequential or separate administration by inhalation in the treatment of respiratory disorders |
| 02/05/2008 | US7328069 Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves |
| 02/05/2008 | US7326691 Pulmonary and/or nasal fungal infection |
| 02/05/2008 | US7326427 Tablet composition containing Kampo medicinal extract and its manufacturing process |
| 02/05/2008 | US7326426 Compositions and medical devices utilizing bioabsorbable liquid polymers |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326422 Dissolvable oxides for biological applications |
| 02/05/2008 | US7326421 Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues |
| 02/05/2008 | US7326404 Konjac-mannan and ginseng compositions and methods and uses thereof |
| 02/05/2008 | US7326294 Preparation of small crystals |
| 02/05/2008 | US7325554 Dental device with improved retention of a flavor and/or chemotherapeutic agent composition |
| 02/05/2008 | US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
| 02/05/2008 | CA2436269C Artificial tear composition containing a combination of three demulcents |
| 02/05/2008 | CA2390746C Quinolinone derivative pharmaceutical composition and production method therefor |
| 02/05/2008 | CA2378824C Coaxial connector having detachable locking sleeve |
| 02/05/2008 | CA2315685C Molecular dispersion composition with enhanced bioavailability |
| 02/05/2008 | CA2313618C Transmucosal formulations of levosimendan |
| 02/05/2008 | CA2307607C Powdery nasal compositions |
| 02/05/2008 | CA2302276C Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 02/05/2008 | CA2274485C Medicinal composition |
| 02/05/2008 | CA2255867C Chitosan induced immunopotentiation |
| 02/05/2008 | CA2191077C Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 02/05/2008 | CA2179304C Stent for liberating drug |
| 02/05/2008 | CA2156255C Soluble thrombomodulin-containing composition |
| 01/31/2008 | WO2008014478A2 Nanocell drug delivery system |
| 01/31/2008 | WO2008014456A2 Combination therapy for otitis with antiseptic and ph adjustment |
| 01/31/2008 | WO2008014448A2 Vascular access device non-adhering membranes |
| 01/31/2008 | WO2008014431A2 Method of treating ocular infections |
| 01/31/2008 | WO2008014200A2 Cyclosporin compositions |
| 01/31/2008 | WO2008014175A2 Granular pharmaceutical compositions |
| 01/31/2008 | WO2008014060A2 Microparticle |
| 01/31/2008 | WO2008014036A1 Aqueous gel formulation and method for inducing topical anesthesia |
| 01/31/2008 | WO2008013955A2 Sustained release formulations for pulmonary delivery |
| 01/31/2008 | WO2008013929A2 Anti-migraine oral spray formulations and methods |
| 01/31/2008 | WO2008013833A2 Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles |
| 01/31/2008 | WO2008013822A2 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 01/31/2008 | WO2008013808A2 High dose orally dissolvable/disintegrable lyophilized dosage form |
| 01/31/2008 | WO2008013807A2 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 01/31/2008 | WO2008013785A2 Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening |
| 01/31/2008 | WO2008013710A2 Chewable tablet containing phenylephrine |
| 01/31/2008 | WO2008013558A2 Polypeptide films and methods |
| 01/31/2008 | WO2008013493A1 Topical treatment of warts |
| 01/31/2008 | WO2008013416A1 Process for preparing powder comprising nanoparticles of sparingly soluble drug |
| 01/31/2008 | WO2008013302A1 Jelly for endoscopic swallowing evaluation |
| 01/31/2008 | WO2008013197A1 Spherical crude granule and method for production thereof |
| 01/31/2008 | WO2008013084A1 Sugar-coated preparation and process for producing the same |
| 01/31/2008 | WO2008012938A1 Aerosol type cosmetic hair preparations |
| 01/31/2008 | WO2008012725A2 A drug delivery system with thermoswitchable membranes |
| 01/31/2008 | WO2008012617A1 Drying of drug-containing particles |
| 01/31/2008 | WO2008012573A1 Coating composition comprising starch |
| 01/31/2008 | WO2008012540A1 N-terminal polysialylation |
| 01/31/2008 | WO2008012495A1 Pharmaceutical formulation comprising donepezil |
| 01/31/2008 | WO2008012474A2 Pharmaceutical compositions of active substances difficult to improperly divert from their intended route of administration |
| 01/31/2008 | WO2008012465A2 Granulated sorbitol and method for the preparation thereof |
| 01/31/2008 | WO2008012394A1 Sclerosing microfoam with co2, preparation device and uses thereof |
| 01/31/2008 | WO2008012367A2 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | WO2008012346A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 01/31/2008 | WO2008012310A1 Caspofungin formulations |
| 01/31/2008 | WO2008012115A1 Pharmaceutical form with multilayer separating layer |
| 01/31/2008 | WO2008012071A2 Pharmaceutical compositions of nicotine and methods of use thereof |
| 01/31/2008 | WO2008011836A2 Ophthalmic solutions |
| 01/31/2008 | WO2008011812A1 Biomimetic cell membrane of phospholipid polymer, preparation method and use thereof |
| 01/31/2008 | WO2007143382A3 Oral liquid loratadine formulations and methods |
| 01/31/2008 | WO2007139827A3 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses |
| 01/31/2008 | WO2007139804A3 Compositions and methods for treating conditions of the nail unit |
| 01/31/2008 | WO2007138022A3 Lipoic acid pellets |
| 01/31/2008 | WO2007137216A3 Gastroretentive sustained release formulations |
| 01/31/2008 | WO2007136586A3 Personal care compositions |
| 01/31/2008 | WO2007127976A3 Particle based molding |
| 01/31/2008 | WO2007125295A3 Treatment of hypothyroidism |
| 01/31/2008 | WO2007122552A3 Device for the controlled release of a substance and method of releasing a substance |
| 01/31/2008 | WO2007103425A3 Kits and methods for preparing pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) |
| 01/31/2008 | WO2007103186A3 Method and apparatus for the preparation of capsules |
| 01/31/2008 | WO2007089652A3 Flavor-enhancing compositions, methods of manufacture, and methods of use |
| 01/31/2008 | WO2007084587A3 Film lined pouch and method of manufacturing this pouch |
| 01/31/2008 | WO2007081996A3 Hemostatic textile |
| 01/31/2008 | WO2007075720A3 Topical mecamylamine formulations for ocular administration and uses thereof |
| 01/31/2008 | WO2007070450A3 Fast-acting oral peptide pharmaceutical products |
| 01/31/2008 | WO2007048524A3 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 01/31/2008 | WO2007020671B1 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 01/31/2008 | WO2005056766A3 TARGETED DRUG DELIVERY USING EphA2 OR Eph4 BINDING MOIETIES |
| 01/31/2008 | US20080027417 Electro-Mechanical System for Electrophysiology and Hemodynamic Studies |
| 01/31/2008 | US20080027410 Vascular access device non-adhering membranes |
| 01/31/2008 | US20080027301 Analyte sensing and response system |
| 01/31/2008 | US20080027136 Compositions and methods for the treatment of cystic fibrosis |
| 01/31/2008 | US20080027120 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 01/31/2008 | US20080027119 Methods and compositions employing bicifadine for the treatment of acute pain, chronic pain, and symptoms of neuropathic disorders |
| 01/31/2008 | US20080027033 Method and Composition for Treatment of Cutaneous Lesions |
| 01/31/2008 | US20080026981 Pharmaceutical Compositions |